Positive regulation of EMT, manifested as down‐regulation of epithelial markers (e.g. E‐cadherin) and up‐regulation of mesenchymal markers (e.g. vimentin), by HULC has been demonstrated in HCC 29 and gastric cancer 20. The gene discussed is HULC; the disease is hepatocellular carcinoma.